Toggle Offcanvas
...
Global Government Tenders

Most trusted source for Tendering Opportunities and Business Intelligence since 2002

Monitoring Of The Medicines Adalimumab And Infliximab, Tests For Concentration In Serum To St. Olav Hospital H

SYKEHUSINNKJOP HF Norway has Released a tender for Monitoring Of The Medicines Adalimumab And Infliximab, Tests For Concentration In Serum To St. Olav Hospital H in Pharmaceuticals. The tender was released on Dec 05, 2024.

Country - Norway

Summary - Monitoring Of The Medicines Adalimumab And Infliximab, Tests For Concentration In Serum To St. Olav Hospital H

Deadline - Jan 16, 2025

GT reference number - 99112819

Product classification - Laboratory reagents

Organization Details:

  Address - Norway

  Contact details - 565656565

  Tender notice no. - 76454545

  GT Ref Id - 99112819

  Document Type - Tender Notices

Notice Details and Documents:

Description - Description: The Department of Immunology and Transfusion Medicine at St.Olavs Hospital uses the above mentioned tests to measure the concentration of the medicines in human serum in patients with autoimmune encephalosis diseases (such as arthritis, Crohn's disease, ulcerative colitis, colorus and multiple sclerosis (MS)). The analyses are part of the disease follow-up, where a monitors medicine concentration.local title:: Monitoring of the medicines Adalimumab and Infliximab, tests for concentration in serum to St. Olav Hospital HContract Duration: : 120 MONTHContract Type: : Supplylocal description: : The Department of Immunology and Transfusion Medicine at St.Olavs Hospital uses the above

Gt Ref Id - 99112819

Deadline - Jan 16, 2025

Share share

Similar Tenders :

Create Account

Why Us

3,00,000 +

Users

190 +

Countries Covered

5,00,000 +

Agencies Tracked

50,000 +

Notices Daily

90 Million +

Database